Abstract:Objective: To investigate the effects of advanced glycation end products (AGEs) on the proliferation and apoptosis of cardiac microvascular endothelial cells (CMECs) in rats and their underlying signaling pathway. Methods: CMECs were isolated from Sprague-Dawley rats. We first examined the effects of AGEs on the proliferation and apoptosis of CMECs and then tested whether protein kinase C (PKC) beta blockers could counteract the effects of AGEs. The PKC agonists phorbol 12-myristate 13-acetate (PMA) and PKC beta blockers were also used to verify whether PKC could act independently on CMECs. The receptor for AGEs (RAGE)-small interfering RNA (siRNA) transfection was used to verify the effect of AGEs on PKC. Following the above steps, we explained whether AGEs regulated the CMEC proliferation and early apoptosis through the PKC beta signaling pathway. Proliferation of CMECs was detected using the Cell Counting Kit-8 (CCK-8) assay, and early apoptosis was determined using the Annexin V- Fluorescein Isothiocyanate (FITC)/propidium iodide (PI) double staining. Expression of proliferation and apoptosis-related proteins and PKC phosphorylation were determined by western blotting analysis. Cell cycle distributions were assayed using a BD FACSCalibur cell-sorting system. Results: AGEs facilitated the proliferation of CMECs, upregulated phosphorylated extracellular signal regulated kinase (p-ERK), and accelerated the entry of cells from G1 phase to the S+G2/M phase, which was consistent with the upregulated cyclin D1 by AGEs. AGEs inhibited early apoptosis of CMECs by increasing the expression of survivin and decreasing the expression of cleaved-caspase3. All these effects can be reversed by PKC beta 1/2inhibitors. In addition, AGE upregulated the RAGE expression and phosphorylation of PKC beta 1/2 in CMECs, while the inhibition of RAGE reversed the phosphorylation, as well as the effects of AGEs on proliferation and apoptosis in CMECs. Conclusion: The study indicated that AGEs facilitated the proliferation and reduced early apoptosis of CMECs via the PKC beta signaling pathway.

Effect of AGEs on Microvascular Endothelial-Cells Angiogenesis by SDF-1/CXCR4 Axis Signaling Pathway

Advanced Glycation End Products Facilitate Proliferation and Reduce Early Apoptosis of Cardiac Microvascular Endothelial Cell Via PKCβ Signaling Pathway: Insight from Diabetic Cardiomyopathy

AGEs Increased Migration and Inflammatory Responses of Adventitial Fibroblasts Via RAGE, MAPK and NF-κB Pathways

The Role of RAGE, MAPK and NF-κB Pathway in the Advanced Glycation End-Products Induced HUVECs Dysfunction

Advanced Glycation End Products Upregulates The Expression Of Connexin43 Via Erk Mapk And Pi3k/Akt Pathways In Human Endothelial Cells

The Effects of DAPT under Advanced Glycation End Products on Microvascular Endothelial Cells

Advanced Glycation End Products Alters Functions of End Othelial Progenitor Cells in Vitro

Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress

Effect of advanced glycosylation end products on expression of connective tissue growth factor in cultured rat aortic smooth muscle cells

Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells

The Depression in Number of Endothelial Progenitor Cells by Advanced Glycation End Products Prepared in Vitro

Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways

Effects of advanced glycation end-products on differentiation of vascular endothelial cells from bone marrow stem cells of mice

Advanced Glycation End Products Impair Function of Late Endothelial Progenitor Cells Through Effects on Protein Kinase Akt and Cyclooxygenase-2

Advanced Glycation End Products Induce Actin Rearrangement and Subsequent Hyperpermeability in Endothelial Cells

Effect and Mechanism of Advanced Glycosylation End Products on the Expression of Scavenger Receptor A in Human Monocyte-Derived Dendritic Cells

Effect of AMD3100 on SDF-1 induced proliferation and migration of endothelial progenitor cells

Advanced Glycation End Products Induce Vascular Smooth Muscle Cell-Derived Foam Cell Formation and Transdifferentiate to a Macrophage-Like State.

Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells

Effects of Advanced Glycation End Products on Activity and Expression of Nitric Oxide Synthase in Human Umbilical Vein Endothelial Cells and the Protective Effects of Metformin

Effects of Advanced Glycation End Products on Oxidative Stress in Endothelial Cells